{"count": 28, "results": [{"_id": "30458653", "pmid": 30458653, "title": "Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM- a retrospective cohort study.", "journal": "J Matern Fetal Neonatal Med", "authors": ["Bashir M", "Aboulfotouh M", "Dabbous Z", "Mokhtar M", "Siddique M", "Wahba R", "Ibrahim A", "Brich SA", "Konje JC", "Abou-Samra AB"], "date": "2020-07-01T00:00:00Z", "doi": "10.1080/14767058.2018.1550480", "meta_date_publication": "2020 Jul", "meta_volume": "33", "meta_issue": "14", "meta_pages": "2366-2371", "score": 50272.68, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-treated-GDM has lower risk of @<m>DISEASE_Fetal_Macrosomia</m> @DISEASE_MESH:D005320 @@@macrosomia@@@ compared to diet-treated GDM- a retrospective cohort study.", "citations": {"NLM": "Bashir M, Aboulfotouh M, Dabbous Z, Mokhtar M, Siddique M, Wahba R, Ibrahim A, Brich SA, Konje JC, Abou-Samra AB. Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM- a retrospective cohort study. J Matern Fetal Neonatal Med. 2020 Jul;33(14):2366-2371. PMID: 30458653", "BibTeX": "@article{30458653, title={Metformin-treated-GDM has lower risk of macrosomia compared to diet-treated GDM- a retrospective cohort study.}, author={Bashir M and Aboulfotouh M and Dabbous Z and Mokhtar M and Siddique M and Wahba R and Ibrahim A and Brich SA and Konje JC and Abou-Samra AB}, journal={J Matern Fetal Neonatal Med}, volume={33}, number={14}, pages={2366-2371}}"}}, {"_id": "34957166", "pmid": 34957166, "pmcid": "PMC8696129", "title": "Physical Exercise vs. Metformin to Improve Delivery- and Newborn-Related Outcomes Among Pregnant Women With Overweight: A Network Meta-Analysis", "journal": "Front Med (Lausanne)", "authors": ["Pascual-Morena C", "Cavero-Redondo I", "Álvarez-Bueno C", "Martínez-Hortelano JA", "Reina-Gutiérrez S", "Saz-Lara A", "Núñez de Arenas-Arroyo S", "Martínez-Vizcaíno V"], "date": "2021-12-09T00:00:00Z", "doi": "10.3389/fmed.2021.796009", "meta_date_publication": "2021", "meta_volume": "8", "meta_issue": "", "meta_pages": "796009", "score": 50272.168, "text_hl": "Tenth, we were unable to perform transitivity analysis for @<m>DISEASE_Fetal_Macrosomia</m> @DISEASE_MESH:D005320 @@@macrosomia@@@ due to lack of studies on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Pascual-Morena C, Cavero-Redondo I, Álvarez-Bueno C, Martínez-Hortelano JA, Reina-Gutiérrez S, Saz-Lara A, Núñez de Arenas-Arroyo S, Martínez-Vizcaíno V. Physical Exercise vs. Metformin to Improve Delivery- and Newborn-Related Outcomes Among Pregnant Women With Overweight: A Network Meta-Analysis Front Med (Lausanne). 2021;8():796009. PMID: 34957166", "BibTeX": "@article{34957166, title={Physical Exercise vs. Metformin to Improve Delivery- and Newborn-Related Outcomes Among Pregnant Women With Overweight: A Network Meta-Analysis}, author={Pascual-Morena C and Cavero-Redondo I and Álvarez-Bueno C and Martínez-Hortelano JA and Reina-Gutiérrez S and Saz-Lara A and Núñez de Arenas-Arroyo S and Martínez-Vizcaíno V}, journal={Front Med (Lausanne)}, volume={8}, pages={796009}}"}}, {"_id": "34569082", "pmid": 34569082, "title": "Metformin for pregnancy and beyond: the pros and cons.", "journal": "Diabet Med", "authors": ["Newman C", "Dunne FP"], "date": "2022-03-01T00:00:00Z", "doi": "10.1111/dme.14700", "meta_date_publication": "2022 Mar", "meta_volume": "39", "meta_issue": "3", "meta_pages": "e14700", "score": 50271.527, "text_hl": "Despite its increasing use, controversy remains surrounding its benefits and risks. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ effectively reduces hyperglycaemia for the mother during pregnancy and it reduces rates of @<m>DISEASE_Fetal_Macrosomia</m> @DISEASE_MESH:D005320 @@@macrosomia@@@ and @DISEASE_Infant_Newborn_Diseases @DISEASE_MESH:D007232 @@@neonatal hypoglycaemia@@@. ", "citations": {"NLM": "Newman C, Dunne FP. Metformin for pregnancy and beyond: the pros and cons. Diabet Med. 2022 Mar;39(3):e14700. PMID: 34569082", "BibTeX": "@article{34569082, title={Metformin for pregnancy and beyond: the pros and cons.}, author={Newman C and Dunne FP}, journal={Diabet Med}, volume={39}, number={3}, pages={e14700}}"}}, {"_id": "37354354", "pmid": 37354354, "pmcid": "PMC10322786", "title": "Focus on Metformin: Its Role and Safety in Pregnancy and Beyond", "journal": "Drugs", "authors": ["Newman C", "Rabbitt L", "Ero A", "Dunne FP"], "date": "2023-06-24T00:00:00Z", "doi": "10.1007/s40265-023-01899-0", "meta_date_publication": "2023 Jun 24", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50267.91, "text_hl": "Focus on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@: Its Role and Safety in Pregnancy and Beyond", "citations": {"NLM": "Newman C, Rabbitt L, Ero A, Dunne FP. Focus on Metformin: Its Role and Safety in Pregnancy and Beyond Drugs. 2023 Jun 24;():. PMID: 37354354", "BibTeX": "@article{37354354, title={Focus on Metformin: Its Role and Safety in Pregnancy and Beyond}, author={Newman C and Rabbitt L and Ero A and Dunne FP}, journal={Drugs}}"}}, {"_id": "36381747", "pmid": 36381747, "pmcid": "PMC9637404", "title": "A Review on the Use of Metformin in Pregnancy and Its Associated Fetal Outcomes", "journal": "Cureus", "authors": ["Verma V", "Mehendale AM"], "date": "2022-10-07T00:00:00Z", "doi": "10.7759/cureus.30039", "meta_date_publication": "2022 Oct", "meta_volume": "14", "meta_issue": "10", "meta_pages": "e30039", "score": 50262.6, "text_hl": "Short-term follow-up of pregnancies that used @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy revealed that there was not any higher chance of @DISEASE_Pre_Eclampsia @DISEASE_MESH:D011225 @@@pre-eclampsia@@@, @DISEASE_Obstetric_Labor_Premature @DISEASE_MESH:D007752 @@@premature labor@@@, neonatal intensive care unit admissions, @<m>DISEASE_Fetal_Macrosomia</m> @DISEASE_MESH:D005320 @@@macrosomia@@@ or @DISEASE_Goldenhar_Syndrome @DISEASE_MESH:D006053 @@@microsomia@@@, and morbidity or mortality of the child up to the first year of life. ", "citations": {"NLM": "Verma V, Mehendale AM. A Review on the Use of Metformin in Pregnancy and Its Associated Fetal Outcomes Cureus. 2022 Oct;14(10):e30039. PMID: 36381747", "BibTeX": "@article{36381747, title={A Review on the Use of Metformin in Pregnancy and Its Associated Fetal Outcomes}, author={Verma V and Mehendale AM}, journal={Cureus}, volume={14}, number={10}, pages={e30039}}"}}, {"_id": "39455749", "pmid": 39455749, "title": "Metformin in gestational diabetes: physiological actions and clinical applications.", "journal": "Nat Rev Endocrinol", "authors": ["Mason T", "Alesi S", "Fernando M", "Vanky E", "Teede HJ", "Mousa A"], "date": "2024-10-25T00:00:00Z", "doi": "10.1038/s41574-024-01049-w", "meta_date_publication": "2024 Oct 25", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.863, "text_hl": "On the basis of current evidence, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduces gestational @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@, @DISEASE_Infant_Newborn_Diseases @DISEASE_MESH:D007232 @@@neonatal hypoglycaemia@@@ and @<m>DISEASE_Fetal_Macrosomia</m> @DISEASE_MESH:D005320 @@@macrosomia@@@ and increases @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity. ", "citations": {"NLM": "Mason T, Alesi S, Fernando M, Vanky E, Teede HJ, Mousa A. Metformin in gestational diabetes: physiological actions and clinical applications. Nat Rev Endocrinol. 2024 Oct 25;():. PMID: 39455749", "BibTeX": "@article{39455749, title={Metformin in gestational diabetes: physiological actions and clinical applications.}, author={Mason T and Alesi S and Fernando M and Vanky E and Teede HJ and Mousa A}, journal={Nat Rev Endocrinol}}"}}, {"_id": "34495393", "pmid": 34495393, "title": "Metformin in Pregnancy for Women with Type 2 Diabetes: a Review.", "journal": "Curr Diab Rep", "authors": ["Benham JL", "Donovan LE", "Yamamoto JM"], "date": "2021-09-08T00:00:00Z", "doi": "10.1007/s11892-021-01409-0", "meta_date_publication": "2021 Sep 8", "meta_volume": "21", "meta_issue": "10", "meta_pages": "36", "score": 50258.26, "text_hl": "RECENT FINDINGS: A large, multicenter, double-blind randomized controlled trial found that @SPECIES_9606 @@@women@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ in pregnancy treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as an adjunct to @GENE_INS @GENE_3630 @@@insulin@@@ therapy had less gestational @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@, @GENE_INS @GENE_3630 @@@insulin@@@ requirements, caesarian sections, @<m>DISEASE_Fetal_Macrosomia</m> @DISEASE_MESH:D005320 @@@macrosomia@@@, and neonatal @DISEASE_Neoplasms_Adipose_Tissue @DISEASE_MESH:D018205 @@@adiposity@@@, but more neonates were @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@small for gestational age@@@ (@DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@SGA@@@) compared with @GENE_INS @GENE_3630 @@@insulin@@@ alone. ", "citations": {"NLM": "Benham JL, Donovan LE, Yamamoto JM. Metformin in Pregnancy for Women with Type 2 Diabetes: a Review. Curr Diab Rep. 2021 Sep 8;21(10):36. PMID: 34495393", "BibTeX": "@article{34495393, title={Metformin in Pregnancy for Women with Type 2 Diabetes: a Review.}, author={Benham JL and Donovan LE and Yamamoto JM}, journal={Curr Diab Rep}, volume={21}, number={10}, pages={36}}"}}, {"_id": "37842989", "pmid": 37842989, "title": "Metformin-associated maternal and neonatal outcomes in women with gestational diabetes - a retrospective cohort study.", "journal": "Ginekol Pol", "authors": ["Yanachkova VE", "Staynova R", "Stoev S", "Kamenov Z"], "date": "2023-10-16T00:00:00Z", "doi": "10.5603/gpl.91632", "meta_date_publication": "2023 Oct 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50251.0, "text_hl": "The lowest incidence of newborns with @<m>DISEASE_Fetal_Macrosomia</m> @DISEASE_MESH:D005320 @@@macrosomia@@@ and @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@neonatal hypoglycemia@@@ has been observed in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ cohort. ", "citations": {"NLM": "Yanachkova VE, Staynova R, Stoev S, Kamenov Z. Metformin-associated maternal and neonatal outcomes in women with gestational diabetes - a retrospective cohort study. Ginekol Pol. 2023 Oct 16;():. PMID: 37842989", "BibTeX": "@article{37842989, title={Metformin-associated maternal and neonatal outcomes in women with gestational diabetes - a retrospective cohort study.}, author={Yanachkova VE and Staynova R and Stoev S and Kamenov Z}, journal={Ginekol Pol}}"}}, {"_id": "35275091", "pmid": 35275091, "pmcid": "PMC9066568", "title": "Effect of metformin on reducing platelet dysfunction in gestational diabetes mellitus: a randomized controlled trial", "journal": "Endocr Connect", "authors": ["Hantrakun P", "Sekararithi R", "Jaiwongkam T", "Kumfu S", "Chai-Adisaksopha C", "Chattipakorn N", "Tongsong T", "Jatavan P"], "date": "2022-04-29T00:00:00Z", "doi": "10.1530/EC-22-0110", "meta_date_publication": "2022 Apr 29", "meta_volume": "11", "meta_issue": "4", "meta_pages": "", "score": 50250.94, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ significantly reduces fetal weight in @SPECIES_9606 @@@women@@@ with @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@GDM@@@, theoretically preventing @<m>DISEASE_Fetal_Macrosomia</m> @DISEASE_MESH:D005320 @@@macrosomia@@@.", "citations": {"NLM": "Hantrakun P, Sekararithi R, Jaiwongkam T, Kumfu S, Chai-Adisaksopha C, Chattipakorn N, Tongsong T, Jatavan P. Effect of metformin on reducing platelet dysfunction in gestational diabetes mellitus: a randomized controlled trial Endocr Connect. 2022 Apr 29;11(4):. PMID: 35275091", "BibTeX": "@article{35275091, title={Effect of metformin on reducing platelet dysfunction in gestational diabetes mellitus: a randomized controlled trial}, author={Hantrakun P and Sekararithi R and Jaiwongkam T and Kumfu S and Chai-Adisaksopha C and Chattipakorn N and Tongsong T and Jatavan P}, journal={Endocr Connect}, volume={11}, number={4}}"}}, {"_id": "31558075", "pmid": 31558075, "title": "Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis.", "journal": "J Matern Fetal Neonatal Med", "authors": ["Bao LX", "Shi WT", "Han YX"], "date": "2021-08-01T00:00:00Z", "doi": "10.1080/14767058.2019.1670804", "meta_date_publication": "2021 Aug", "meta_volume": "34", "meta_issue": "16", "meta_pages": "2741-2753", "score": 50250.758, "text_hl": "Among these, seventeen RCTs (N = 2828 participants) were included for quantitative analyses and seven studies were included only for qualitative synthesis. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ lowered the risk of pregnancy-induced @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ (p = .03; risk ratio (RR) = 0.64; confidence interval (95%CI) [0.44, 0.95]), large for gestational age babies (p = .04; RR = 0.82; 95% CI [0.68, 0.99]), @<m>DISEASE_Fetal_Macrosomia</m> @DISEASE_MESH:D005320 @@@macrosomia@@@ (p = .01; RR = 0.63; 95%CI [0.45, 0.90]), neonatal @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@hypoglycemia@@@ (p = .001; RR = 0.72; 95%CI [0.59, 0.88]), and neonatal intensive care unit admission (p = .01; RR = 0.74; 95%CI [0.58, 0.94]). ", "citations": {"NLM": "Bao LX, Shi WT, Han YX. Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2021 Aug;34(16):2741-2753. PMID: 31558075", "BibTeX": "@article{31558075, title={Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis.}, author={Bao LX and Shi WT and Han YX}, journal={J Matern Fetal Neonatal Med}, volume={34}, number={16}, pages={2741-2753}}"}}]}